_ v4.jpg)
Dr. Wael Mohammed Osman holds a medical degree from the University of Khartoum, Sudan, and a PhD in Molecular Genetics from the Graduate School of Medicine, University of Tokyo, Japan; the home of the Biobank Japan Project, and a major collaborator on the Human Genome Project. Additionally, he holds an MSc degree in International Public Health from Liverpool John Moores University, UK, and a Postgraduate Certificate in Clinical Research from Harvard Medical School, USA. Using association analyses and genome sequencing, he examines the genetics of metabolic traits (type 2 diabetes, gestational diabetes, obesity, and cardiovascular disease). Furthermore, he studies the genetic and metabolic factors involved in the development of diabetic kidney disease (DKD) and its complications. The goal of his research is to develop better prevention and treatment strategies for DKD. Additionally, he is exploring methods for combining traditional clinical data and medical diagnostics with modern big data analysis in order to improve the accuracy of his strategies. His current research involves the identification of genetic and metabolomic markers that can be used to detect 1) gestational diabetes mellitus and predict pregnancy outcomes, and 2) obesity, particularly among adolescents.
